Olusola Obayomi-Davies MD
Central Nervous System Cancer, Gastrointestinal Cancer, Thoracic Cancer
Wellstar Kennestone Hospital
Join to View Full Profile
320 Kennestone BlvdMarietta, GA 30061
Phone+1 770-793-7500
Dr. Obayomi-Davies is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Olusola Obayomi-Davies is a radiation oncologist in Marietta , GA. He received his medical degree from Howard University College of Medicine and has been in practice 6 years.
He specializes in stereotactic radiosurgery and stereotactic body radiotherapy in treating lung, central nervous system tumors, and pancreatic cancer.
He has speciality expertise in utilizing the CyberKnife Radiosurgery platform in treating recurrent and previously radiated cancers.
Education & Training
MedStar Health Georgetown UniversityResidency, Radiation Oncology, 2012 - 2016- MedStar Health Georgetown University/Harbor HospitalInternship, Transitional Year, 2011 - 2012
Howard University College of MedicineClass of 2011
Certifications & Licensure
GA State Medical License 2019 - 2026
PA State Medical License 2016 - 2021
DC State Medical License 2012 - 2016
American Board of Radiology Radiation Oncology
Clinical Trials
- A Multi-Institutional Registry for CyberKnife Stereotactic Accelerated Partial Breast Irradiation (CK-SAPBI) Start of enrollment: 2015 May 01
- CyberKnife Dose Escalation Prostate Cancer Trial Start of enrollment: 2018 Jul 12
Publications & Presentations
PubMed
- 4 citationsRationale for Utilization of Hydrogel Rectal Spacers in Dose Escalated SBRT for the Treatment of Unfavorable Risk Prostate Cancer.Michael C Repka, Michael Creswell, Jonathan W Lischalk, Michael Carrasquilla, Matthew Forsthoefel
Frontiers in Oncology. 2022-01-01 - 1 citationsDose matters for stereotactic body radiotherapy for early stage non-small cell lung cancer.Christian C. Okoye, C. Jane Cho, Mitchell Liu, Alexander V. Louie, Olusola Obayomi-Davies
Annals of Translational Medicine. 2020-09-01 - 12 citationsRepeat Thoracic Stereotactic Body Radiation Therapy (SBRT) for Nonsmall Cell Lung Cancer: Long-Term Outcomes, Toxicity, and Dosimetric Considerations.A. Ricco, Sara Barlow, Jing Feng, Janson Jacob, Alicia Lozano
Advances in Radiation Oncology. 2020-06-25
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
